Astena Holdings Co., Ltd. Logo

Astena Holdings Co., Ltd.

Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.

8095 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町四丁目8番2号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Astena Holdings Co., Ltd., formerly Iwaki & Co Ltd, is a diversified holding company established on June 1, 2021, following the transition of the IWAKI Group. The company operates through several core business segments: Fine Chemicals, Health & Beauty Care (HBC), Medical, Food, and Industrial Chemicals. Astena Holdings develops, manufactures, and wholesales a broad portfolio of products, including pharmaceuticals, medical devices, cosmetic ingredients, functional food ingredients, and specialty chemicals. A key subsidiary, Meltex, is a leading provider of surface finishing chemicals used in various industries, including semiconductors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-18 08:03
M&A Activity
臨時報告書
Japanese 28.5 KB
2025-07-11 08:07
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-07-11 08:06
Interim Report
半期報告書-第86期(2024/12/01-2025/11/30)
Japanese 245.6 KB
2025-03-06 07:04
Post-Annual General Meeting Information
臨時報告書
Japanese 23.9 KB
2025-02-27 08:04
Regulatory News Service
内部統制報告書-第85期(2023/12/01-2024/11/30)
Japanese 22.1 KB
2025-02-27 08:03
Regulatory News Service
確認書
Japanese 8.2 KB
2025-02-27 08:02
Annual Report
有価証券報告書-第85期(2023/12/01-2024/11/30)
Japanese 1.4 MB
2025-01-30 07:05
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2024-07-12 08:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:05
Quarterly Report
四半期報告書-第85期第2四半期(2024/03/01-2024/05/31)
Japanese 249.6 KB
2024-04-12 08:13
Quarterly Report
確認書
Japanese 8.1 KB
2024-04-12 08:10
Quarterly Report
四半期報告書-第85期第1四半期(2023/12/01-2024/02/29)
Japanese 203.6 KB
2024-03-04 08:10
Regulatory News Service
臨時報告書
Japanese 25.0 KB
2024-02-28 08:35
Registration Form
確認書
Japanese 8.1 KB
2024-02-28 08:34
Governance Information
内部統制報告書-第84期(2022/12/01-2023/11/30)
Japanese 22.1 KB

Automate Your Workflow. Get a real-time feed of all Astena Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Astena Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea 065170
BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France BOI
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina BSNL
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea 003000
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea 402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom CNSL
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF

Talk to a Data Expert

Have a question? We'll get back to you promptly.